This situation has concluded
It was preserved as a record on September 9; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
7 clusters · 40 sources · 19 days · First seen · Last updated
Sildenafil shows anti‑metastatic promise
Overview
Late July 2026 pre‑clinical work from U.S. and Israeli labs showed that sildenafil, the active ingredient of Viagra, blocks PDE5, raises cGMP, and sequesters cholesterol in lysosomes, suppressing metastatic spread in mouse models of breast, lung, colon and prostate cancer. The July 22 report detailed the same cholesterol‑dependent mechanism and noted that co‑administration with statins further reduced tumor‑cell migration. Analyses of Israeli health‑service records covering nearly five million patients found improved survival among cancer patients prescribed sildenafil, especially when combined with statins. A July 30 study in *Cancer Research* by Ayelet Erez and Yarden Ariav described the PDE5‑cGMP‑NPC1 pathway and confirmed the retrospective survival benefit. Follow‑up papers on July 31 and August 1 reiterated the mechanistic findings and emphasized that the National Cancer Institute views the repurposing approach as promising but experimental, warning against self‑medication. On August 3, a further pre‑clinical report from the Weizmann Institute and the U.S. National Cancer Institute reaffirmed these results, showing marked reductions in metastasis formation, especially when combined with statins. On August 6, a new *Cancer Research* article by the same collaborative team expanded the preclinical evidence, highlighting the strongest anti‑metastatic signals in breast, melanoma and lung cancers and announcing plans for clinical trials, particularly in triple‑negative breast cancer. The same day, researchers at the Weizmann Institute reported that sildenafil blocked cholesterol transport into tumor cells, reducing movement of human breast, lung and colon cancer cells, with the greatest effect in triple‑negative breast cancer. In mouse models, tumor spread to the lungs fell by more than 50%. A two-decade analysis of about five million Clalit health-system records showed a 26% lower five-year mortality risk for cancer patients using sildenafil, an effect amplified when patients also used statins. These findings reinforce the move toward clinical trials in women with triple‑negative breast cancer.
Entities
Weizmann Institute of Science · Ayelet Erez · Sildenafil (Viagra) · Statins · Sildenafil
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 7 SOURCES] Researchers identified a mechanism by which sildenafil can inhibit cancer cell metastasis.
- [● 7 SOURCES] Sildenafil inhibits phosphodiesterase type 5 (PDE5), raising intracellular cGMP levels.
- [● 7 SOURCES] Elevated cGMP interferes with NPC1 protein, reducing cholesterol transport in tumor cells.
- [● 7 SOURCES] Reduced cholesterol availability hampers tumor cell migration and metastasis formation.
- [● 7 SOURCES] The anti‑metastatic effect is enhanced when sildenafil is combined with statins.
- [● 7 SOURCES] Laboratory tests on animal and human tumor cells showed increased susceptibility to sildenafil‑induced metabolic disruption.
- [● 7 SOURCES] Retrospective clinical data indicated higher survival rates for cancer patients who used sildenafil, especially with statins.
- [● 7 SOURCES] The study was conducted by the Weizmann Institute of Science in Israel with U.S. researchers and published in Cancer Research.
- [● 7 SOURCES] Researchers caution that clinical trials are needed before sildenafil can be used as a cancer treatment.
- [● 7 SOURCES] Combining sildenafil with statins enhances the anti‑metastatic effect.
- [● 7 SOURCES] Patients who took sildenafil and statins at least six months before a cancer diagnosis had higher survival rates.
- [● 7 SOURCES] The research focused on triple‑negative breast cancer, melanoma, lung cancer, and also examined colorectal and prostate cancers.
- [● 7 SOURCES] Sildenafil blocks cholesterol transport into tumor cells, reducing cancer metastasis.
- [● 7 SOURCES] Laboratory experiments showed sildenafil slowed movement and growth of human breast, lung and colon cancer cells.
- [● 7 SOURCES] In mouse models, sildenafil reduced lung metastasis by more than 50 %.
- [● 7 SOURCES] Analysis of about five million Clalit patient records over 20 years found cancer patients who used sildenafil had a 26 % lower five‑year mortality risk than non‑users.
- [● 7 SOURCES] The study was conducted by scientists at the Weizmann Institute of Science in Israel, in collaboration with the US National Cancer Institute and Israel's Clalit health system, and published in Cancer
- [● 5 SOURCES] Sildenafil blocks the enzyme PDE5, reducing cholesterol transport into tumor cells and limiting metastasis.
- [● 5 SOURCES] The study used mouse models, human tumor‑cell cultures, and health‑record data from about five million Clalit members over 20 years.
- [● 5 SOURCES] The findings were published in the journal Cancer Research.
- [● 5 SOURCES] Researchers plan clinical trials, especially in women with triple‑negative breast cancer.
- [● 5 SOURCES] The active ingredient of Viagra is sildenafil.
- [○ 1 SOURCE] The study focused on triple‑negative breast cancer, melanoma and lung cancer models.
- [○ 1 SOURCE] The U.S. National Cancer Institute highlighted the research on its social‑media platform X.
Timeline
-
[HEALTH] 3 sourcesSildenafil may help limit cancer metastasis, researchers find
Scientists have found that sildenafil, the active ingredient in Viagra, may limit cancer metastasis by disrupting cholesterol trafficking within cancer cells, according to research from the Weizmann Institute.
-
[HEALTH] 8 sourcesViagra's active ingredient sildenafil shown to curb cancer metastasis
Weizmann Institute researchers found sildenafil blocks cholesterol transport in tumor cells, reducing metastasis in labs and mouse models; patient data show a 26% lower five‑year mortality, with added benefit –
-
[HEALTH] 2 sourcesSildenafil shown to curb cancer metastasis in preclinical studies
A Weizmann Institute and U.S. NCI study found sildenafil reduces cancer cell migration and metastasis in lab models, with enhanced effect when paired with statins; health‑record data suggest improved survival,
-
[HEALTH] 9 sourcesViagra's active ingredient sildenafil shown to limit cancer metastasis in preclinical study
A Weizmann Institute study in Cancer Research found sildenafil, Viagra’s active ingredient, blocks cholesterol use in cancer cells, reducing metastasis in lab models, especially with statins; clinical trials –
-
[HEALTH] 7 sourcesWeizmann Institute study finds Viagra may block cancer metastasis
Weizmann Institute researchers report that Viagra (sildenafil) blocks tumor cholesterol transport, reducing metastasis in lab studies and linking to higher survival in patients, especially with statins.
-
[HEALTH] 4 sourcesViagra's active ingredient shows potential to block cancer metastasis
Weizmann Institute researchers report sildenafil (Viagra) blocks a cholesterol‑related pathway, reducing cancer cell spread in labs and improving survival in Israeli patient data, but clinical trials are needed
-
[HEALTH] 7 sourcesViagra (sildenafil) may block cancer metastasis in preclinical research
US‑Israel researchers found sildenafil may hinder cancer metastasis in mouse models by disrupting cholesterol transport, especially when paired with statins.
Sources
brasilemfolhas.com · deia.eus · deultimominuto.net · dol.com.br · elsol.com.ar · ensegundos.do · fehmarn24.de · hrvatska-danas.com · instinctmagazine.com · jwire.com.au · katalogfirm.pl · knowridge.com · kopalniawiedzy.pl · kurierverlag.de · latestly.com · leinetal24.de · m.nautil.us · mag.newsweek.com · mayacomunicacion.com.mx · mobil.krone.at · multimediosprisma.com · n1info.hr · nationalgeographic.com.es · oglobo.globo.com · okdiario.com · orienteeringonline.net · priskalkulator.no · santiago30caballeros.com · sdpnoticias.com · secolo-trentino.com · sibiu100.ro · sintinta.com.ar · tessenderlo.com · thej.ca · theneutral.pk · timesnownews.com · tocka.com.mk · tribunaonline.com.br · xeu.com.mx · xeu.mx
This summary has been updated 13 times: see revision history